DAISY TORRES: Open Payments
NPI 1689020729 · RIVERSIDE, CA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$505 in 28 payments from 9 companies in 2025. Trend: 2023 $644 · 2024 $283 · 2025 $505
Food & beverage: $505
| Company | Payments | Amount |
|---|---|---|
| Lilly USA, LLC | 12 | $146 |
| Novo Nordisk Inc | 4 | $100 |
| Corcept Therapeutics | 4 | $84 |
| SANOFI-AVENTIS U.S. LLC | 3 | $66 |
| Astellas Pharma US Inc | 1 | $26 |
| Bayer Healthcare Pharmaceuticals Inc. | 1 | $22 |
| Amgen Inc. | 1 | $22 |
| Abbott Laboratories | 1 | $21 |
| Exact Sciences Corporation | 1 | $18 |
Products named: MOUNJARO, Korlym, Wegovy, TZIELD, Ozempic, Veozah, Kerendia, OTEZLA.
Industry payments across CA — which companies pay providers there.
